There are no articles in this category. If subcategories display on this page, they may have articles.
Business & Industry
- AstraZeneca and Oracle launch global AI collaboration to advance clinical trial optimisation and support better patient outcomes
- Abbott launches 'Mind Your Behind' campaign to encourage Americans 45+ to screen for colorectal cancer
- Pfizer advances today's cancer care and tomorrow's potential breakthroughs at ESMO
- An open letter from the Chairs of AstraZeneca, Boehringer Ingelheim, Chiesi Group, Ipsen, GSK, Novo, Novartis, Roche, and Sanofi
- Sanofi and Cheplapharm to create new strategic partnership in mature medicines
Research & Development
- Cancer cells killed with their own carbon monoxide
- Can we stop antibiotic resistance in ruining promising drugs before they reach patients?
- New therapeutic approach for the brain disorder SCA3
- Drug substance reduces blood vessel malformations in the brain
- Creating 'satellite maps' of proteins could transform drug therapies
- New AI platform helps uncover promising cancer drug combinations
- AI aids in the development of new active ingredients
Conferences & Events
- SAE Media Group proudly presents the 4th Annual AI in Drug Discovery Conference
- SAE Media Group's 6th annual 3D Cell Culture Conference
- CPHI Frankfurt returns to pre-pandemic strength as pharma industry booms again
- 14th Annual RNA Therapeutics: Investigating the next generation of genetic medicine through RNA based therapies
- CPHI Excellence in Pharma Award Winners 2022
- CPHI Frankfurt Report predicts huge funding overhang to drive contract services growth
- CPHI Frankfurt 2022: Global pharma confidence hits record high in the annual CPHI Pharma Index
Regulatory Affairs
- FDA launches new program to advance neuroscience medical product development
- FDA issues final guidance on Prescription drug apps and software
- FDA approves first in class targeted therapy for metastatic pancreatic cancer
- FDA approves first drug of its kind for polycythemia vera, a rare blood disorder
- FDA expands artificial intelligence capabilities with agentic AI deployment